{"category":{"kind":"industry","slug":"genomics","name":"Genomics","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T05:52:10.577Z","updated_at":"2026-09-03T05:52:10.577Z","example":false,"profile_url":"/industries/genomics","is_stub":true,"member_count":20,"member_counts":{"company":20}},"members":[{"listing_type":"company","name":"Gamgee","slug":"gamgee","tagline":"Scalable Personalised Cancer Treatment","description":"​Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved\n\nGamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring\n\n​We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next\n\nGamgee is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://www.gamgee.io/","is_stealth":false,"normalized_domain":"gamgee.io","normalized_url_key":"gamgee.io","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6f6bf83f60f82f47f1a3b961153608810edebb3b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/gamgee","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.gamgee.io/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.gamgee.io/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Genomics","Oncology","AI"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:33:26.675Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","Biotech","Genomics","Oncology","AI"],"one_liner_for_search":"Gamgee — Scalable Personalised Cancer Treatment (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Gamgee Technologies","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:33:26.675Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:33:26.675Z","updated_at":"2026-09-03T08:33:26.675Z"}},{"listing_type":"company","name":"Anto Biosciences","slug":"anto-biosciences","tagline":"A Foundation Model for Microbial Communities.","description":"Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures. \n\nFounded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed sparsification) and David (Harvard Medical School Gastroenterology, J&J), second-time founders who published the breakthrough at leading machine learning AI conferences and Nature.\n\nAnto Biosciences is a Y Combinator company (Fall 2025). YC-listed status: Active.","url":"https://anto.bio/","is_stealth":false,"normalized_domain":"anto.bio","normalized_url_key":"anto.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/83f56c369ac0fb5e70438516e774b8603717940a.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/anto-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://anto.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://anto.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Artificial Intelligence","Generative AI","Biotech","Genomics","Drug discovery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:16:14.842Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Fall 2025","Artificial Intelligence","Generative AI","Biotech","Genomics","Drug discovery"],"one_liner_for_search":"Anto Biosciences — A Foundation Model for Microbial Communities. (Y Combinator Fall 2025)","canonical_facts":["Y Combinator batch: Fall 2025","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare","Former names: Anto","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:16:14.842Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"generative-ai","name":"Generative AI","note":null,"profile_url":"/industries/generative-ai"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:16:14.842Z","updated_at":"2026-09-03T08:16:14.842Z"}},{"listing_type":"company","name":"WhiteLab Genomics","slug":"whitelab-genomics","tagline":"Unleashing the potential of DNA and RNA based therapies using AI","description":"We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.\n\nWhiteLab Genomics is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"https://whitelabgx.com/","is_stealth":false,"normalized_domain":"whitelabgx.com","normalized_url_key":"whitelabgx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ba69864f65b85fda9f05c3280bc3b39f42500013.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/whitelab-genomics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://whitelabgx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://whitelabgx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Artificial Intelligence","Gene Therapy","Cell Therapy","Genomics"],"stage":null,"founded_year":null,"location":"Paris, Île-de-France, France; Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:11:19.037Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","Artificial Intelligence","Gene Therapy","Cell Therapy","Genomics"],"one_liner_for_search":"WhiteLab Genomics — Unleashing the potential of DNA and RNA based therapies using AI (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 40","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): France, United States of America, Europe, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:11:19.037Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:11:19.037Z","updated_at":"2026-09-03T07:11:19.037Z"}},{"listing_type":"company","name":"Nest Genomics","slug":"nest-genomics","tagline":"Software to launch and integrate genetics into clinical care","description":"Nest is a lab-agnostic, comprehensive solution for organizations to launch and implement large-scale genomic programs. The platform includes the ability to triage, consent, and counsel patients for genetic testing, provide EMR-integrated clinical decision support for providers managing patients with genetic results, and manage patients’ clinical needs across the continuum of care.\n\nNest Genomics is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"https://www.nestgenomics.com/","is_stealth":false,"normalized_domain":"nestgenomics.com","normalized_url_key":"nestgenomics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/c965d20fc0bacd98d8b38c9742848bdb11b05841.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nest-genomics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.nestgenomics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nestgenomics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Healthcare IT","SaaS","Health Tech","Digital Health","Genomics","Primary Care"],"stage":null,"founded_year":null,"location":"New York City, NY, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:01:31.375Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","SaaS","Health Tech","Digital Health","Genomics","Primary Care"],"one_liner_for_search":"Nest Genomics — Software to launch and integrate genetics into clinical care (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 14","YC industry: Healthcare","YC subindustry: Healthcare / Healthcare IT","Former names: Applied Genomics, Guide Genomics, Pepper Genomics","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:01:31.375Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/industries/health-tech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthcare-it","name":"Healthcare IT","note":null,"profile_url":"/industries/healthcare-it"},{"kind":"industry","slug":"primary-care","name":"Primary Care","note":null,"profile_url":"/industries/primary-care"},{"kind":"industry","slug":"saas","name":"SaaS","note":null,"profile_url":"/industries/saas"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:01:31.375Z","updated_at":"2026-09-03T07:01:31.375Z"}},{"listing_type":"company","name":"Genomelink","slug":"genomelink","tagline":"DNA App Store","description":"Genomelink is a DNA App Store. If you’ve taken a DNA test from Ancestry or 23andMe, you can upload your data to Genomelink to unlock a wide range of DNA apps: a 2,000+ region ancestry breakdown, insights from 400+ ancient DNA samples, analysis of 350+ genetic traits, unique DNA matches, and more.\n\nExplore our latest genealogy app, YourRoots (https://yourroots.com/), which transforms your family tree into an interactive global map visualization.\n\nWe believe consumer genomics today is where the internet was in the 1990s. Over 50 million people in the U.S. have already tested their DNA, and this number will grow into the billions globally in the coming decades. Genomelink aims to become the default DNA data hub and app store for this genomic future.\n\nOur mission:\n- Build the world’s #1 platform for consumer genomics apps\n- Help people discover their family roots and unite the world  \n- Create an infruscrucure for consumer genomics\n\nGenomelink is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://genomelink.io/","is_stealth":false,"normalized_domain":"genomelink.io","normalized_url_key":"genomelink.io","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/61c755cb25ac9262366c90a49a285fcd2783647e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/genomelink","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://genomelink.io/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://genomelink.io/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Consumer Health and Wellness","Consumer Health Services","Genomics"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:56:26.989Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Consumer Health Services","Genomics"],"one_liner_for_search":"Genomelink — DNA App Store (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 15","YC industry: Healthcare","YC subindustry: Healthcare / Consumer Health and Wellness","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:56:26.989Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"consumer-health-and-wellness","name":"Consumer Health and Wellness","note":null,"profile_url":"/industries/consumer-health-and-wellness"},{"kind":"industry","slug":"consumer-health-services","name":"Consumer Health Services","note":null,"profile_url":"/industries/consumer-health-services"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:56:26.989Z","updated_at":"2026-09-03T06:56:26.989Z"}},{"listing_type":"company","name":"Talus Bio","slug":"talus-bio","tagline":"Discovering drugs that target the DNA regulome","description":"We have built a platform that enables drug discovery and development for previously undruggable genome regulators (\"the regulome\"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.\n\nTalus Bio is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://www.talus.bio/","is_stealth":false,"normalized_domain":"talus.bio","normalized_url_key":"talus.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6677b768e2a0c2a30de4f32fc3f4f2dce1baea6a.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/talus-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.talus.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.talus.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Genomics","Drug discovery"],"stage":null,"founded_year":null,"location":"Seattle, WA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:48:19.888Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Biotech","Genomics","Drug discovery"],"one_liner_for_search":"Talus Bio — Discovering drugs that target the DNA regulome (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 16","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:48:19.888Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:48:19.888Z","updated_at":"2026-09-03T06:48:19.888Z"}},{"listing_type":"company","name":"Kernal Biologics","slug":"kernal-biologics","tagline":"Kernal is creating mRNA 2.0 therapies that work in specific cells","description":"Kernal Bio is a biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted cell delivery and minimal off-target effects. Our KR-402 program achieves over 90% delivery efficiency with T-cell-targeted LNPs, enabling direct CAR-T programming within the body and resulting in B-cell depletion within a week.\n \nKernal Bio is led by a team with experience from MIT, Harvard, Merck, and BMS, boasting three FDA-approved therapies and over 120 patents. Based in Cambridge, MA, we are backed by Hummingbird Ventures, Amgen Ventures, HBM, and even NASA.\n\nWith roots at MIT, Harvard and Biopharma, Kernal’s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. Sr. VP of R&D Manfred Kraus is a leader in immuno-oncology, who was most recently Scientific Sr. Director at Bristol-Myers Squibb (BMS).\n\nKernal Biologics is a Y Combinator company (Summer 2020). YC-listed status: Active.","url":"https://www.kernalbio.com/","is_stealth":false,"normalized_domain":"kernalbio.com","normalized_url_key":"kernalbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/1534fd5c3c1e4705596c793a4a59a28da388bacf.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/kernal-biologics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.kernalbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.kernalbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Artificial Intelligence","Biotech","Genomics"],"stage":null,"founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:34:16.014Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2020","Artificial Intelligence","Biotech","Genomics"],"one_liner_for_search":"Kernal Biologics — Kernal is creating mRNA 2.0 therapies that work in specific cells (Y Combinator Summer 2020)","canonical_facts":["Y Combinator batch: Summer 2020","YC company status: Active","Team size (per YC directory): 20","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:34:16.014Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:34:16.014Z","updated_at":"2026-09-03T06:34:16.014Z"}},{"listing_type":"company","name":"Ochre Bio","slug":"ochre-bio","tagline":"RNA medicines for liver diseases","description":"Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.\n\nOchre Bio is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.ochre-bio.com/","is_stealth":false,"normalized_domain":"ochre-bio.com","normalized_url_key":"ochre-bio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/d80993cda53fffe2cfd91762d630c27dc21561bf.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/ochre-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.ochre-bio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.ochre-bio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Genomics"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom; Oxford, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:32:30.493Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Biotech","Genomics"],"one_liner_for_search":"Ochre Bio — RNA medicines for liver diseases (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 50","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United Kingdom, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:32:30.493Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:32:30.493Z","updated_at":"2026-09-03T06:32:30.493Z"}},{"listing_type":"company","name":"Sequence Bio","slug":"sequence-bio","tagline":"Discovering the true signals of disease to power life-changing drugs.","description":"90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.\n\nSequence Bio is a Y Combinator company (Summer 2019). YC-listed status: Active.","url":"https://www.sequencebio.com/","is_stealth":false,"normalized_domain":"sequencebio.com","normalized_url_key":"sequencebio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/819f850ae7a7b60333fcb1b8a2c4ef4e8a3d2fd3.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sequence-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.sequencebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.sequencebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Genomics","Therapeutics","Drug discovery"],"stage":null,"founded_year":null,"location":"St. John's, NL, Canada","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:26:39.301Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2019","Genomics","Therapeutics","Drug discovery"],"one_liner_for_search":"Sequence Bio — Discovering the true signals of disease to power life-changing drugs. (Y Combinator Summer 2019)","canonical_facts":["Y Combinator batch: Summer 2019","YC company status: Active","Team size (per YC directory): 52","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): Canada, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:26:39.301Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:26:39.301Z","updated_at":"2026-09-03T06:26:39.301Z"}},{"listing_type":"company","name":"Kern Systems","slug":"kern-systems","tagline":"Using DNA to store data.","description":"DNA has emerged as a compelling data storage medium due to its density, longevity, and eternal relevance compared to current memory technologies. However, the high price of synthesizing DNA remains a major bottleneck for adoption of this promising storage solution. We are pioneering new approaches to synthesizing DNA for data storage with enzymes and custom digital codecs. We are building an interdisciplinary team to build the world's most scalable information infrastructure in DNA. \n\nWe seek technical experts in enzyme engineering, chemistry, hardware engineering, and information theory. We also seek business development to identify emerging markets for early use cases of our technology.\n\nKern Systems is a Y Combinator company (Summer 2019). YC-listed status: Active.","url":"https://www.kernsystems.com/","is_stealth":false,"normalized_domain":"kernsystems.com","normalized_url_key":"kernsystems.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/960f475f7529b916c176fbf83565873d60242a91.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/kern-systems","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.kernsystems.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.kernsystems.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Genomics","Nanotechnology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:25:07.223Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2019","Genomics","Nanotechnology"],"one_liner_for_search":"Kern Systems — Using DNA to store data. (Y Combinator Summer 2019)","canonical_facts":["Y Combinator batch: Summer 2019","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:25:07.223Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:25:07.223Z","updated_at":"2026-09-03T06:25:07.223Z"}},{"listing_type":"company","name":"Spiral Genetics","slug":"spiral-genetics","tagline":"Large Scale Genomic Data Mining Software","description":"Spiral Genetics (YC W19) makes genomic data mining software to compare large populations of whole human genomes. Our customers are genetics testing companies, governments of countries, and pharma companies. We train our machine learning algorithms to enable large scale comparison of genomes to power novel discoveries, enabling new diagnostics and drugable targets.\n\nSpiral Genetics is a Y Combinator company (Winter 2019). YC-listed status: Inactive.","url":"https://www.spiralgenetics.com/","is_stealth":false,"normalized_domain":"spiralgenetics.com","normalized_url_key":"spiralgenetics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/822d8282aa459c05cf652eefd3f059118ec38f90.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/spiral-genetics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.spiralgenetics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.spiralgenetics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Healthcare Services","Machine Learning","Genomics"],"stage":null,"founded_year":null,"location":"Seattle, WA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:22:24.414Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","Machine Learning","Genomics"],"one_liner_for_search":"Spiral Genetics — Large Scale Genomic Data Mining Software (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Inactive","Team size (per YC directory): 7","YC industry: Healthcare","YC subindustry: Healthcare / Healthcare Services","Former names: Spiral Genetics, Inc.","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:22:24.414Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthcare-services","name":"Healthcare Services","note":null,"profile_url":"/industries/healthcare-services"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:22:24.414Z","updated_at":"2026-09-03T06:22:24.414Z"}},{"listing_type":"company","name":"XGenomes","slug":"xgenomes","tagline":"XGenomes is building the sequencing technology of the future.","description":"At XGenomes, we are building a technology comprising novel biochemistry, hardware and  algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation;  we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive \"dark matter\" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables.\n\nXGenomes is a Y Combinator company (Winter 2019). YC-listed status: Active.","url":"https://www.xgenomes.com/","is_stealth":false,"normalized_domain":"xgenomes.com","normalized_url_key":"xgenomes.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/4cca3d33a3a643c65629ce3164548e924340e550.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/xgenomes","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.xgenomes.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.xgenomes.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Genomics"],"stage":null,"founded_year":null,"location":"Boston, MA, USA; Cambridge, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:20:38.767Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","Genomics"],"one_liner_for_search":"XGenomes — XGenomes is building the sequencing technology of the future. (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: XGenomes Corp.","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:20:38.767Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:20:38.767Z","updated_at":"2026-09-03T06:20:38.767Z"}},{"listing_type":"company","name":"Volta Labs, Inc.","slug":"volta-labs-inc","tagline":"Unlocking the utility of genomics for the world.","description":"Volta Labs is a genomics applications company that has developed a cutting-edge digital fluidics platform to maximize performance and scalability of sample preparation in genomics while providing unparalleled consistency. Volta is transforming the way biological research and analyses are performed, allowing scientists to focus on what they do best -- pushing the boundaries of biology.\n\nAs a collective of scientists and builders working at the intersection of engineering and biology, we imagine a world where extracting vital information from biological samples is as simple as pressing a button. That's our vision, and we're turning it into reality.\n\nOur HQ is in Boston’s Seaport, where we develop and manufacture our technology. We believe in cross-functional collaboration and continuous learning –  whether your interest is in biology, MechEng, CompEng, or simply joining a fast-growing startup striving to make the world a better place, we'd love to welcome you to our team. Check out some of our blog posts to learn more about work life at Volta.\n\nVolta Labs, Inc. is a Y Combinator company (Winter 2019). YC-listed status: Active.","url":"https://voltalabs.com/","is_stealth":false,"normalized_domain":"voltalabs.com","normalized_url_key":"voltalabs.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/373e91d473569c304899f7cec638ddc0b46d10d6.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/volta-labs-inc","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://voltalabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://voltalabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Hard Tech","Hardware","Robotics","Genomics","Biotechnology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA; Cambridge, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:20:28.268Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","Hard Tech","Hardware","Robotics","Genomics","Biotechnology"],"one_liner_for_search":"Volta Labs, Inc. — Unlocking the utility of genomics for the world. (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Active","Team size (per YC directory): 50","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: Volta Labs Inc.","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:20:28.268Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/industries/hard-tech"},{"kind":"industry","slug":"hardware","name":"Hardware","note":null,"profile_url":"/industries/hardware"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"robotics","name":"Robotics","note":null,"profile_url":"/industries/robotics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:20:28.268Z","updated_at":"2026-09-03T06:20:28.268Z"}},{"listing_type":"company","name":"Probably Genetic","slug":"probably-genetic","tagline":"Patient Intelligence Platform for Genetic Disease","description":"Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients. In doing so, we help patients access diagnoses, clinical trials, and treatments as early as possible.\n\nProbably Genetic is a Y Combinator company (Winter 2019). YC-listed status: Active.","url":"https://www.probablygenetic.com/","is_stealth":false,"normalized_domain":"probablygenetic.com","normalized_url_key":"probablygenetic.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/9558e9a7114240a3f1e2a6378bd906ffe21826f3.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/probably-genetic","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.probablygenetic.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.probablygenetic.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Health Tech","Biotech","Genomics","AI"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:19:33.516Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","Health Tech","Biotech","Genomics","AI"],"one_liner_for_search":"Probably Genetic — Patient Intelligence Platform for Genetic Disease (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Active","Team size (per YC directory): 17","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: Aiwa Health","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:19:33.516Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/industries/health-tech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:19:33.516Z","updated_at":"2026-09-03T06:19:33.516Z"}},{"listing_type":"company","name":"Circumvent","slug":"circumvent","tagline":"Utilizing monogenic disorders to inform and solve highly complex…","description":"Utilizing monogenic disorders to inform and solve highly complex…\n\nCircumvent is a Y Combinator company (Summer 2018). YC-listed status: Active.","url":"https://www.circumventpharmaceuticals.com/","is_stealth":false,"normalized_domain":"circumventpharmaceuticals.com","normalized_url_key":"circumventpharmaceuticals.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b5fd725fe8e2cac76ed87eacf3161d3f37da8f61.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/circumvent","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.circumventpharmaceuticals.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.circumventpharmaceuticals.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Neurotechnology","Biotech","Genomics"],"stage":null,"founded_year":null,"location":"Portland, OR, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:17:39.490Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Neurotechnology","Biotech","Genomics"],"one_liner_for_search":"Circumvent — Utilizing monogenic disorders to inform and solve highly complex… (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Circumvent Pharmaceuticals","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:17:39.490Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"neurotechnology","name":"Neurotechnology","note":null,"profile_url":"/industries/neurotechnology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:17:39.490Z","updated_at":"2026-09-03T06:17:39.490Z"}},{"listing_type":"company","name":"Sigma Genetics","slug":"sigma-genetics","tagline":"Sigma Genetics is a biotechnology company that is building…","description":"Sigma Genetics develops devices that can deliver DNA, RNA, and other charged molecules into cells by using magnetic fields. When compared to conventional electroporation, this technique has several key advantages, which include: the absence of arcing, the ability to scale, and the benefit of being non-invasive for in vivo applications. This platform technology can be applied to a wide range of applications- cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.\n\nSigma Genetics is a Y Combinator company (Winter 2017). YC-listed status: Active.","url":"https://sigmagenetics.com/","is_stealth":false,"normalized_domain":"sigmagenetics.com","normalized_url_key":"sigmagenetics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/3d163f0758d535d9b800f2a88bdefffc73c5bbe2.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sigma-genetics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://sigmagenetics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://sigmagenetics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Genomics"],"stage":null,"founded_year":null,"location":"Seattle, WA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:08:10.283Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2017","Biotech","Genomics"],"one_liner_for_search":"Sigma Genetics — Sigma Genetics is a biotechnology company that is building… (Y Combinator Winter 2017)","canonical_facts":["Y Combinator batch: Winter 2017","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:08:10.283Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:08:10.283Z","updated_at":"2026-09-03T06:08:10.283Z"}},{"listing_type":"company","name":"Helix Nanotechnologies","slug":"helix-nanotechnologies","tagline":"Next-generation mRNA platform to solve cancer, COVID and climate.","description":"Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button.\n\nBy focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity.\n\nRigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas.\n\nWe've started rolling out some of our new tech — moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.\n\nHelix Nanotechnologies is a Y Combinator company (Winter 2017). YC-listed status: Active.","url":"https://www.helixnano.com/","is_stealth":false,"normalized_domain":"helixnano.com","normalized_url_key":"helixnano.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/f05a634de42c2c96484608b63b33b99fd27aa56e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/helix-nanotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.helixnano.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.helixnano.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Artificial Intelligence","Biotech","Genomics","Nanotechnology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA; Cambridge, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:07:34.508Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2017","Artificial Intelligence","Biotech","Genomics","Nanotechnology"],"one_liner_for_search":"Helix Nanotechnologies — Next-generation mRNA platform to solve cancer, COVID and climate. (Y Combinator Winter 2017)","canonical_facts":["Y Combinator batch: Winter 2017","YC company status: Active","Team size (per YC directory): 22","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Helix Nanotechnologies","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:07:34.508Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:07:34.508Z","updated_at":"2026-09-03T06:07:34.508Z"}},{"listing_type":"company","name":"Shield Bio","slug":"shield-bio","tagline":"Bringing 3rd generation, nanopore sequencing to healthcare to solve…","description":"Shield Bio is a precision medicine company with a\nproprietary platform that enables reliable nanopore\nsequencing in under a minute, in a clinical setting. It is\nfocused on bringing 3rd generation or \"nanopore\"\nsequencing into clinical use to deliver on the promise of\nprecision medicine. Shield is initially using the technology to\nimprove the treatment of infectious disease and address the\nunmet clinical need of sepsis, which kills 300,000 people a\nyear in the US alone.\n\nShield Bio is a Y Combinator company (Summer 2016). YC-listed status: Inactive.","url":"http://shieldbio.com/","is_stealth":false,"normalized_domain":"shieldbio.com","normalized_url_key":"shieldbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/shield-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"http://shieldbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"http://shieldbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Genomics","Nanotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; San Jose, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:02:37.868Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2016","Healthcare","Genomics","Nanotechnology"],"one_liner_for_search":"Shield Bio — Bringing 3rd generation, nanopore sequencing to healthcare to solve… (Y Combinator Summer 2016)","canonical_facts":["Y Combinator batch: Summer 2016","YC company status: Inactive","Team size (per YC directory): 28","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: TL Biolabs, Shield Diagnostics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:02:37.868Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:02:37.868Z","updated_at":"2026-09-03T06:02:37.868Z"}},{"listing_type":"company","name":"BillionToOne","slug":"billiontoone","tagline":"The genetic testing platform detecting and measuring disease.","description":"BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.\n\nBillionToOne is a Y Combinator company (Summer 2017). YC-listed status: Public.","url":"https://www.billiontoone.com/","is_stealth":false,"normalized_domain":"billiontoone.com","normalized_url_key":"billiontoone.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/7374f48e30f2dabadb3413903af69fcda589d67f.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/billiontoone","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.billiontoone.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.billiontoone.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Genomics"],"stage":"public","founded_year":null,"location":"San Francisco, CA, USA; Menlo Park, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:01:41.871Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2017","Diagnostics","Genomics"],"one_liner_for_search":"BillionToOne — The genetic testing platform detecting and measuring disease. (Y Combinator Summer 2017)","canonical_facts":["Y Combinator batch: Summer 2017","YC company status: Public","Team size (per YC directory): 300","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:01:41.871Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:01:41.871Z","updated_at":"2026-09-03T06:01:41.871Z"}},{"listing_type":"company","name":"One Codex","slug":"one-codex","tagline":"Data platform for metagenomics and the microbiome.","description":"One Codex is a data platform for applied microbial genomics, enabling new and valuable applications in clinical diagnostics, food safety, and biosecurity. Acquired by Invitae (NVTA) in February 2021. Spun out as an independent company in September 2022.\n\nOne Codex is a Y Combinator company (Summer 2014). YC-listed status: Acquired.","url":"https://www.onecodex.com/","is_stealth":false,"normalized_domain":"onecodex.com","normalized_url_key":"onecodex.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/5eedcdf8d152fac7180dc5402647f58cd164448a.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/one-codex","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.onecodex.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.onecodex.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Healthcare IT","Biotech","Diagnostics","Genomics"],"stage":null,"founded_year":null,"location":"Boston, MA, USA; San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T05:52:10.577Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2014","Biotech","Diagnostics","Genomics"],"one_liner_for_search":"One Codex — Data platform for metagenomics and the microbiome. (Y Combinator Summer 2014)","canonical_facts":["Y Combinator batch: Summer 2014","YC company status: Acquired","Team size (per YC directory): 16","YC industry: Healthcare","YC subindustry: Healthcare / Healthcare IT","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T05:52:10.577Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthcare-it","name":"Healthcare IT","note":null,"profile_url":"/industries/healthcare-it"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T05:52:10.577Z","updated_at":"2026-09-03T05:52:10.577Z"}}],"total":20,"limit":50,"offset":0}